91 related articles for article (PubMed ID: 25289770)
1. Protective roles of aldo-keto reductase 1B10 and autophagy against toxicity induced by p-quinone metabolites of tert-butylhydroquinone in lung cancer A549 cells.
Endo S; Nishiyama A; Suyama M; Takemura M; Soda M; Chen H; Tajima K; El-Kabbani O; Bunai Y; Hara A; Matsunaga T; Ikari A
Chem Biol Interact; 2015 Jun; 234():282-9. PubMed ID: 25289770
[TBL] [Abstract][Full Text] [Related]
2. Reduction of cytotoxic p-quinone metabolites of tert-butylhydroquinone by human aldo-keto reductase (AKR) 1B10.
Matsunaga T; Endo S; Takemura M; Soda M; Yamamura K; Tajima K; Miura T; Terada T; El-Kabbani O; Hara A
Drug Metab Pharmacokinet; 2012; 27(5):553-8. PubMed ID: 22498646
[TBL] [Abstract][Full Text] [Related]
3. Purification and some properties of two enzymes from rat liver cytosol that catalyze carbonyl reduction of 6-tert-butyl-2, 3-epoxy-5-cyclohexene-1,4-dione, a metabolite of 3-tert-butyl-4-hydroxyanisole.
Tajima K; Hashizaki M; Yamamoto K; Narimatsu S; Mizutani T
Arch Biochem Biophys; 1999 Jan; 361(2):207-14. PubMed ID: 9882448
[TBL] [Abstract][Full Text] [Related]
4. Cell death induced by the phenolic antioxidant tert-butylhydroquinone and its metabolite tert-butylquinone in human monocytic leukemia U937 cells.
Okubo T; Yokoyama Y; Kano K; Kano I
Food Chem Toxicol; 2003 May; 41(5):679-88. PubMed ID: 12659721
[TBL] [Abstract][Full Text] [Related]
5. Oxidative Conversion Mediates Antiproliferative Effects of tert-Butylhydroquinone: Structure and Activity Relationship Study.
Sanidad KZ; Sukamtoh E; Wang W; Du Z; Florio E; He L; Xiao H; Decker EA; Zhang G
J Agric Food Chem; 2016 May; 64(19):3743-8. PubMed ID: 27111399
[TBL] [Abstract][Full Text] [Related]
6. Paradoxical cytotoxicity of tert-butylhydroquinone in vitro: What kills the untreated cells?
Braeuning A; Vetter S; Orsetti S; Schwarz M
Arch Toxicol; 2012 Sep; 86(9):1481-7. PubMed ID: 22466069
[TBL] [Abstract][Full Text] [Related]
7. Aldo-keto reductase 1B10 promotes development of cisplatin resistance in gastrointestinal cancer cells through down-regulating peroxisome proliferator-activated receptor-γ-dependent mechanism.
Matsunaga T; Suzuki A; Kezuka C; Okumura N; Iguchi K; Inoue I; Soda M; Endo S; El-Kabbani O; Hara A; Ikari A
Chem Biol Interact; 2016 Aug; 256():142-53. PubMed ID: 27417252
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide confers cisplatin resistance in human lung cancer cells through upregulation of aldo-keto reductase 1B10 and proteasome.
Matsunaga T; Yamaji Y; Tomokuni T; Morita H; Morikawa Y; Suzuki A; Yonezawa A; Endo S; Ikari A; Iguchi K; El-Kabbani O; Tajima K; Hara A
Free Radic Res; 2014 Nov; 48(11):1371-85. PubMed ID: 25156503
[TBL] [Abstract][Full Text] [Related]
9. Exposure to 9,10-phenanthrenequinone accelerates malignant progression of lung cancer cells through up-regulation of aldo-keto reductase 1B10.
Matsunaga T; Morikawa Y; Haga M; Endo S; Soda M; Yamamura K; El-Kabbani O; Tajima K; Ikari A; Hara A
Toxicol Appl Pharmacol; 2014 Jul; 278(2):180-9. PubMed ID: 24813866
[TBL] [Abstract][Full Text] [Related]
10. Rabbit 3-hydroxyhexobarbital dehydrogenase is a NADPH-preferring reductase with broad substrate specificity for ketosteroids, prostaglandin D₂, and other endogenous and xenobiotic carbonyl compounds.
Endo S; Matsunaga T; Matsumoto A; Arai Y; Ohno S; El-Kabbani O; Tajima K; Bunai Y; Yamano S; Hara A; Kitade Y
Biochem Pharmacol; 2013 Nov; 86(9):1366-75. PubMed ID: 23994167
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of 3-tert-butyl-4-hydroxyanisole by microsomal fractions and isolated rat hepatocytes.
Cummings SW; Ansari GA; Guengerich FP; Crouch LS; Prough RA
Cancer Res; 1985 Nov; 45(11 Pt 2):5617-24. PubMed ID: 4053035
[TBL] [Abstract][Full Text] [Related]
12. Aldo-keto reductase 1B10 protects human colon cells from DNA damage induced by electrophilic carbonyl compounds.
Zu X; Yan R; Pan J; Zhong L; Cao Y; Ma J; Cai C; Huang D; Liu J; Chung FL; Liao DF; Cao D
Mol Carcinog; 2017 Jan; 56(1):118-129. PubMed ID: 26969882
[TBL] [Abstract][Full Text] [Related]
13. Dihydrocapsaicin (DHC), a saturated structural analog of capsaicin, induces autophagy in human cancer cells in a catalase-regulated manner.
Oh SH; Kim YS; Lim SC; Hou YF; Chang IY; You HJ
Autophagy; 2008 Nov; 4(8):1009-19. PubMed ID: 18818525
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of aldo-keto reductase AKR1B10 gene expression by a phorbol ester via the ERK/c-Jun signaling pathway.
Nishinaka T; Miura T; Sakou M; Hidaka C; Sasaoka C; Okamura A; Okamoto A; Terada T
Chem Biol Interact; 2015 Jun; 234():274-81. PubMed ID: 25463304
[TBL] [Abstract][Full Text] [Related]
15. Roles of aldo-keto reductases 1B10 and 1C3 and ATP-binding cassette transporter in docetaxel tolerance.
Matsunaga T; Saito H; Endo S; Iguchi K; Soda M; El-Kabbani O; Hara A; Ikari A
Free Radic Res; 2016 Dec; 50(12):1296-1308. PubMed ID: 27629782
[TBL] [Abstract][Full Text] [Related]
16. Participation of covalent modification of Keap1 in the activation of Nrf2 by tert-butylbenzoquinone, an electrophilic metabolite of butylated hydroxyanisole.
Abiko Y; Miura T; Phuc BH; Shinkai Y; Kumagai Y
Toxicol Appl Pharmacol; 2011 Aug; 255(1):32-9. PubMed ID: 21651925
[TBL] [Abstract][Full Text] [Related]
17. Aldo-keto reductases mediate constitutive and inducible protection against aldehyde toxicity in human neuroblastoma SH-SY5Y cells.
Lyon RC; Li D; McGarvie G; Ellis EM
Neurochem Int; 2013 Jan; 62(1):113-21. PubMed ID: 23084985
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of 3-tert-butyl-4-hydroxyanisole by horseradish peroxidase and hydrogen peroxide.
Tajima K; Hashizaki M; Yamamoto K; Mizutani T
Drug Metab Dispos; 1992; 20(6):816-20. PubMed ID: 1362932
[TBL] [Abstract][Full Text] [Related]
19. The effect of tert-butylhydroquinone-induced oxidative stress in MDBK cells using XTT assay: implication of tert-butylhydroquinone-induced NADPH generating enzymes.
Naoi T; Shibuya N; Inoue H; Mita S; Kobayashi S; Watanabe K; Orino K
J Vet Med Sci; 2010 Mar; 72(3):321-6. PubMed ID: 19996565
[TBL] [Abstract][Full Text] [Related]
20. Involvement of the aldo-keto reductase, AKR1B10, in mitomycin-c resistance through reactive oxygen species-dependent mechanisms.
Matsunaga T; Yamane Y; Iida K; Endo S; Banno Y; El-Kabbani O; Hara A
Anticancer Drugs; 2011 Jun; 22(5):402-8. PubMed ID: 21317765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
